Ryan Deschner

Stock Analyst at Jefferies

(4.77)
# 86
Out of 4,853 analysts
12
Total ratings
81.82%
Success rate
47.52%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Ryan Deschner

Inozyme Pharma
May 16, 2025
Downgrades: Hold
Price Target: $15$4
Current: $3.99
Upside: +0.25%
Apellis Pharmaceuticals
May 9, 2025
Downgrades: Outperform
Price Target: $75$52
Current: $19.10
Upside: +172.25%
Liquidia
May 9, 2025
Maintains: Strong Buy
Price Target: $27$29
Current: $18.02
Upside: +60.93%
Trevi Therapeutics
Mar 10, 2025
Upgrades: Strong Buy
Price Target: $9$29
Current: $6.74
Upside: +330.27%
Ardelyx
Feb 21, 2025
Reiterates: Strong Buy
Price Target: $15$13
Current: $3.64
Upside: +257.14%
ARS Pharmaceuticals
Jan 14, 2025
Maintains: Strong Buy
Price Target: $26$28
Current: $13.44
Upside: +108.33%